Skip to main content

30 June 2026

Last updated: Thursday 25 June 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Oxford BioMedica perfects lentiviral vectors for gene therapy

Tuesday 22 March 2011

Interviewee/Contributor

Stuart Naylor

Organisation

Oxford Biomedica Plc

Organisations

Jon Rees Associates
Paul Capital Healthcare
Odlander, Fredrikson and Co AB
OutSee Ltd
Truffle Capital
BDO LLP
Probiodrug AG
Immune Targeting Systems Ltd
Johnson & Johnson Innovation Center, London
Immunicum AB

Interviewees and Contributers

Gil Beyen
Antonio Lanzavecchia
Mick Cooper
Marc Rogers
Øystein Rekdal
Khalid Ishaque
Miguel Forte
Alex Gee
Morten Grunnet
Regina Hodits

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Evotec names head of in silico and AI

Saturday 20 June 2026

Forbion promotes senior officers, appoints operating partner

Saturday 20 June 2026

Specialist CDMO Ardena appoints CSO

Saturday 20 June 2026

CellaVision names CEO

Saturday 20 June 2026

FundaMental Pharma names CMO to lead depression candidate

Saturday 20 June 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form